Next Article in Journal
DNA Damage Repair Classifier Defines Distinct Groups in Hepatocellular Carcinoma
Next Article in Special Issue
Co-Targeting MAP Kinase and Pi3K-Akt-mTOR Pathways in Meningioma: Preclinical Study of Alpelisib and Trametinib
Previous Article in Journal
Association between Adverse Events and Prognosis in Patients with Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab: A Multicenter Retrospective Study
 
 
Article

Article Versions Notes

Cancers 2022, 14(17), 4285; https://doi.org/10.3390/cancers14174285
Action Date Notes Link
article xml file uploaded 1 September 2022 12:23 CEST Original file -
article xml uploaded. 1 September 2022 12:23 CEST Update https://www.mdpi.com/2072-6694/14/17/4285/xml
article pdf uploaded. 1 September 2022 12:23 CEST Version of Record https://www.mdpi.com/2072-6694/14/17/4285/pdf
article supplementary file uploaded. 1 September 2022 12:23 CEST - https://www.mdpi.com/2072-6694/14/17/4285#supplementary
article html file updated 1 September 2022 12:24 CEST Original file -
article html file updated 28 February 2023 11:52 CET Update https://www.mdpi.com/2072-6694/14/17/4285/html
Back to TopTop